Potent influence of bovine serum proteins in experimental dendritic cell-based vaccination Protocols

被引:32
作者
Toldbod, HE
Agger, R
Bolund, L
Hokland, M
机构
[1] Aarhus Univ, Dept Human Genet, DK-8000 Aarhus C, Denmark
[2] Univ Aarhus, Dept Med Microbiol & Immunol, DK-8000 Aarhus, Denmark
关键词
D O I
10.1046/j.1365-3083.2003.01267.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Typically autologous dendritic cells (DCs) intended for vaccination are generated from bone marrow derived stem cells or blood monocytes, loaded with antigen and introduced into the organism. However, addition of serum to DC culture medium is often necessary. Thus, serum proteins will be taken up and presented by the DCs together with other antigens. If heterologous serum is used, some of the serum proteins might be antigenic and thus induce a strong immune response when introduced in the recipient. We used the murine model of malignant melanoma, B16, to investigate the consequences of addition of fetal calf serum (FCS) to the medium for culturing murine DCs. The results showed that vaccination of mice with DCs cultured in vitro in the presence of FCS but in the absence of extraneous turnout antigens, protected the mice from challenge with B16 turnout cells similarly cultured in FCS. This protection could not be elicited by vaccination with FCS alone. Interestingly, the protective effect of DC vaccination was abolished when the challenging B16 tumour cells were free of serum proteins. Thus, these results show that DCs grown in the presence of FCS Are able to induce immunity, which may be mistaken to be tumour immunity.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 21 条
  • [1] Agger R, 2000, SCAND J IMMUNOL, V52, P138
  • [2] AXELSON NH, 1983, SCAND J IMMUNOL S10, V17
  • [3] Böhm W, 1998, J IMMUNOL, V161, P897
  • [4] Eggert AO, 2002, EUR J IMMUNOL, V32, P122, DOI 10.1002/1521-4141(200201)32:1<122::AID-IMMU122>3.0.CO
  • [5] 2-C
  • [6] GENERATION OF LARGE NUMBERS OF DENDRITIC CELLS FROM MOUSE BONE-MARROW CULTURES SUPPLEMENTED WITH GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR
    INABA, K
    INABA, M
    ROMANI, N
    AYA, H
    DEGUCHI, M
    IKEHARA, S
    MURAMATSU, S
    STEINMAN, RM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (06) : 1693 - 1702
  • [7] Kociková A, 1998, J IMMUNOL, V161, P4033
  • [8] RETRACTED: Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids (Retracted article. See vol. 9, p. 1221, 2003)
    Kugler, A
    Stuhler, G
    Walden, P
    Zöller, G
    Zobywalski, A
    Brossart, P
    Trefzer, U
    Ullrich, S
    Müller, CA
    Becker, V
    Gross, AJ
    Hemmerlein, B
    Kanz, L
    Müller, GA
    Ringert, RH
    [J]. NATURE MEDICINE, 2000, 6 (03) : 332 - 336
  • [9] An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow
    Lutz, MB
    Kukutsch, N
    Ogilvie, ALJ
    Rössner, S
    Koch, F
    Romani, N
    Schuler, G
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 223 (01) : 77 - 92
  • [10] Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells
    Mackensen, A
    Dräger, R
    Schlesier, M
    Mertelsmann, R
    Lindemann, A
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 49 (03) : 152 - 156